Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies

Abstract Background Selective fetal growth restriction in monochorionic twin pregnancies is associated with an increased risk of perinatal mortality and morbidity and represents a clinical dilemma. Interventions include expectant management with early preterm delivery if there are signs of fetal com...

Full description

Bibliographic Details
Main Authors: Asma Khalil, James M. N. Duffy, Helen Perry, Wessel Ganzevoort, Keith Reed, Ahmet A. Baschat, Jan Deprest, Eduardo Gratacos, Kurt Hecher, Liesbeth Lewi, Enrico Lopriore, Dick Oepkes, Aris Papageorghiou, Sanne J. Gordijn, On behalf of the International Collaboration to Harmonise Outcomes for Selective Fetal Growth Restriction (CHOOSE-FGR)
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Trials
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13063-018-3153-y
id doaj-6d0f73e7709242b9a556a9e402bf2a3c
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Asma Khalil
James M. N. Duffy
Helen Perry
Wessel Ganzevoort
Keith Reed
Ahmet A. Baschat
Jan Deprest
Eduardo Gratacos
Kurt Hecher
Liesbeth Lewi
Enrico Lopriore
Dick Oepkes
Aris Papageorghiou
Sanne J. Gordijn
On behalf of the International Collaboration to Harmonise Outcomes for Selective Fetal Growth Restriction (CHOOSE-FGR)
spellingShingle Asma Khalil
James M. N. Duffy
Helen Perry
Wessel Ganzevoort
Keith Reed
Ahmet A. Baschat
Jan Deprest
Eduardo Gratacos
Kurt Hecher
Liesbeth Lewi
Enrico Lopriore
Dick Oepkes
Aris Papageorghiou
Sanne J. Gordijn
On behalf of the International Collaboration to Harmonise Outcomes for Selective Fetal Growth Restriction (CHOOSE-FGR)
Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies
Trials
Selective fetal growth restriction
Selective intrauterine growth restriction
Core outcome set
Modified Delphi method
Modified Nominal Group Technique
Consensus development study
author_facet Asma Khalil
James M. N. Duffy
Helen Perry
Wessel Ganzevoort
Keith Reed
Ahmet A. Baschat
Jan Deprest
Eduardo Gratacos
Kurt Hecher
Liesbeth Lewi
Enrico Lopriore
Dick Oepkes
Aris Papageorghiou
Sanne J. Gordijn
On behalf of the International Collaboration to Harmonise Outcomes for Selective Fetal Growth Restriction (CHOOSE-FGR)
author_sort Asma Khalil
title Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies
title_short Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies
title_full Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies
title_fullStr Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies
title_full_unstemmed Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies
title_sort study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies
publisher BMC
series Trials
issn 1745-6215
publishDate 2019-01-01
description Abstract Background Selective fetal growth restriction in monochorionic twin pregnancies is associated with an increased risk of perinatal mortality and morbidity and represents a clinical dilemma. Interventions include expectant management with early preterm delivery if there are signs of fetal compromise, selective termination of the compromised twin, fetoscopic laser coagulation of the communicating placental vessels or termination of the whole pregnancy. Previous studies evaluating interventions have reported many different outcomes and outcome measures. Such variation makes comparing, contrasting, and combining results challenging, limiting ongoing research on this uncommon condition to inform clinical practice. We aim to produce, disseminate, and implement a core outcome set for selective fetal growth restriction research in monochorionic twin pregnancies. Methods An international steering group, including professionals, researchers, and lay experts, has been established to oversee the development of this core outcome set. The methods have been guided by the Core Outcome Measures in Effectiveness Trials Initiative Handbook. Potential core outcomes will be developed by undertaking a systematic review of studies evaluating interventions for selective fetal growth restriction in monochorionic twin pregnancies. Potential core outcomes will be entered into a three-round Delphi survey and key stakeholders including clinical professionals, researchers, and lay experts will be invited to participate. Repeated reflection and rescoring of individual outcomes should encourage group and individual stakeholder convergence towards consensus outcomes which will be entered into a modified Nominal Group Technique to finalize the core outcome set. Once core outcomes have been agreed, we will establish standardized definitions and recommend high-quality measurement instruments for each outcome. Discussion The development, dissemination, and implementation of a core outcome set for selective fetal growth restriction should ensure that future research protocols select, collect, and report outcomes and outcome measures in a standardized manner. Data synthesis will be possible on a broad level and rigorous implementation should advance the quality of research studies and their effective use in order to guide clinical practice, improve patient care, maternal, short-term perinatal outcomes, and long-term neurodevelopmental outcomes. Trial registration Core Outcome Measures in Effectiveness Trials (COMET) registration number: 998. International Prospective Register of Systematic Reviews (PROSPERO) registration number: CRD42018092697. 18th April 2018.
topic Selective fetal growth restriction
Selective intrauterine growth restriction
Core outcome set
Modified Delphi method
Modified Nominal Group Technique
Consensus development study
url http://link.springer.com/article/10.1186/s13063-018-3153-y
work_keys_str_mv AT asmakhalil studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT jamesmnduffy studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT helenperry studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT wesselganzevoort studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT keithreed studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT ahmetabaschat studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT jandeprest studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT eduardogratacos studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT kurthecher studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT liesbethlewi studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT enricolopriore studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT dickoepkes studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT arispapageorghiou studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT sannejgordijn studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
AT onbehalfoftheinternationalcollaborationtoharmoniseoutcomesforselectivefetalgrowthrestrictionchoosefgr studyprotocoldevelopingdisseminatingandimplementingacoreoutcomesetforselectivefetalgrowthrestrictioninmonochorionictwinpregnancies
_version_ 1724770275422109696
spelling doaj-6d0f73e7709242b9a556a9e402bf2a3c2020-11-25T02:43:18ZengBMCTrials1745-62152019-01-012011710.1186/s13063-018-3153-yStudy protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnanciesAsma Khalil0James M. N. Duffy1Helen Perry2Wessel Ganzevoort3Keith Reed4Ahmet A. Baschat5Jan Deprest6Eduardo Gratacos7Kurt Hecher8Liesbeth Lewi9Enrico Lopriore10Dick Oepkes11Aris Papageorghiou12Sanne J. Gordijn13On behalf of the International Collaboration to Harmonise Outcomes for Selective Fetal Growth Restriction (CHOOSE-FGR)Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George’s University of LondonBalliol College, University of OxfordVascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George’s University of LondonDepartment of Obstetrics and Gynecology, Academic Medical Center Amsterdam, University of AmsterdamTwin and Multiple Births Association (TAMBA), The Manor House Manor ParkThe Johns Hopkins Center for Fetal TherapyDepartment of Obstetrics and Gynecology, University Hospitals of KU LeuvenBarcelona Center for Maternal-Fetal and Neonatal Medicine, Hospital Clínic and Hospital Sant Joan de Deu, Universitat de Barcelona; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), and Centre for Biomedical Research on Rare Diseases (CIBER-ER)Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-EppendorfDepartment of Obstetrics and Gynecology, University Hospitals of KU LeuvenDivision of Fetal Medicine, Department of Obstetrics, Leiden University Medical CenterDivision of Fetal Medicine, Department of Obstetrics, Leiden University Medical CenterFetal Medicine Unit, Department of Obstetrics and Gynaecology, St. George’s University Hospitals NHS Foundation TrustDepartment of Obstetrics and Gynecology, University Medical Center Groningen, University of GroningenAbstract Background Selective fetal growth restriction in monochorionic twin pregnancies is associated with an increased risk of perinatal mortality and morbidity and represents a clinical dilemma. Interventions include expectant management with early preterm delivery if there are signs of fetal compromise, selective termination of the compromised twin, fetoscopic laser coagulation of the communicating placental vessels or termination of the whole pregnancy. Previous studies evaluating interventions have reported many different outcomes and outcome measures. Such variation makes comparing, contrasting, and combining results challenging, limiting ongoing research on this uncommon condition to inform clinical practice. We aim to produce, disseminate, and implement a core outcome set for selective fetal growth restriction research in monochorionic twin pregnancies. Methods An international steering group, including professionals, researchers, and lay experts, has been established to oversee the development of this core outcome set. The methods have been guided by the Core Outcome Measures in Effectiveness Trials Initiative Handbook. Potential core outcomes will be developed by undertaking a systematic review of studies evaluating interventions for selective fetal growth restriction in monochorionic twin pregnancies. Potential core outcomes will be entered into a three-round Delphi survey and key stakeholders including clinical professionals, researchers, and lay experts will be invited to participate. Repeated reflection and rescoring of individual outcomes should encourage group and individual stakeholder convergence towards consensus outcomes which will be entered into a modified Nominal Group Technique to finalize the core outcome set. Once core outcomes have been agreed, we will establish standardized definitions and recommend high-quality measurement instruments for each outcome. Discussion The development, dissemination, and implementation of a core outcome set for selective fetal growth restriction should ensure that future research protocols select, collect, and report outcomes and outcome measures in a standardized manner. Data synthesis will be possible on a broad level and rigorous implementation should advance the quality of research studies and their effective use in order to guide clinical practice, improve patient care, maternal, short-term perinatal outcomes, and long-term neurodevelopmental outcomes. Trial registration Core Outcome Measures in Effectiveness Trials (COMET) registration number: 998. International Prospective Register of Systematic Reviews (PROSPERO) registration number: CRD42018092697. 18th April 2018.http://link.springer.com/article/10.1186/s13063-018-3153-ySelective fetal growth restrictionSelective intrauterine growth restrictionCore outcome setModified Delphi methodModified Nominal Group TechniqueConsensus development study